Related Experiment Video
Updated: Aug 14, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 31, 2013
[Activity of antithrombin III in the blood of patients with bladder cancer]
Z Zietek1, I Iwan-Zietek, M Kotschy
1Katedry i Kliniki Urologii, Bydgoszczy.
Abstract:
The activity of antithrombin III (AT III) in the blood of patients with bladder carcinoma was examined. It was shown an increase of AT III activity in comparison with control group. The changes of AT III activity in the blood of patients with bladder carcinoma can be the symptoms of an increased risk of haemorrhagic or thromboembolic complications.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Imaging Studies III: Computed Tomography

